-
2
-
-
20144370294
-
First NIH/Office of Rare Diseases Conference on Cystinosis: Past, present, and future
-
Kleta R, Kaskel F, Dohil R, Goodyer P, Guay-Woodford L, Harms E, Ingelfinger J, Koch V, Langman C, Leonard M, Mannon R, Sarwal M, Schneider J, Skovby F, Sonies B, Thoene G, Trauner D, Gahl W (2005) First NIH/Office of Rare Diseases Conference on Cystinosis: Past, present, and future. Pediatr Nephrol 20:452-454
-
(2005)
Pediatr Nephrol
, vol.20
, pp. 452-454
-
-
Kleta, R.1
Kaskel, F.2
Dohil, R.3
Goodyer, P.4
Guay-Woodford, L.5
Harms, E.6
Ingelfinger, J.7
Koch, V.8
Langman, C.9
Leonard, M.10
Mannon, R.11
Sarwal, M.12
Schneider, J.13
Skovby, F.14
Sonies, B.15
Thoene, G.16
Trauner, D.17
Gahl, W.18
-
3
-
-
0042061361
-
Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood
-
Fleitz J, Wootton-Gorges S, Wyatt-Ashmead J, McGavran L, Koyle M, West D, Kurzrock E, Martin K, Odom L (2003) Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol 33:540-545
-
(2003)
Pediatr Radiol
, vol.33
, pp. 540-545
-
-
Fleitz, J.1
Wootton-Gorges, S.2
Wyatt-Ashmead, J.3
McGavran, L.4
Koyle, M.5
West, D.6
Kurzrock, E.7
Martin, K.8
Odom, L.9
-
4
-
-
0037365791
-
Prognostic factors of renal cell carcinoma
-
Mejean A, Oudard S, Thiounn N (2003) Prognostic factors of renal cell carcinoma. J Urol 169:821-827
-
(2003)
J Urol
, vol.169
, pp. 821-827
-
-
Mejean, A.1
Oudard, S.2
Thiounn, N.3
-
5
-
-
28844484134
-
Renal-Cell Carcinoma
-
Cohen H, McGovern F (2005) Renal-Cell Carcinoma. N Engl J Med 353:2477-2490
-
(2005)
N Engl J Med
, vol.353
, pp. 2477-2490
-
-
Cohen, H.1
McGovern, F.2
-
6
-
-
0033964458
-
Renal cell carcinoma: Prognostic significance of incidentally detected tumors
-
Tsui K, Shvarts O, Smith R, Figlin R, DeKernion J, Belldegrun A (2000) Renal cell carcinoma: Prognostic significance of incidentally detected tumors. J Urol 163:426-430
-
(2000)
J Urol
, vol.163
, pp. 426-430
-
-
Tsui, K.1
Shvarts, O.2
Smith, R.3
Figlin, R.4
DeKernion, J.5
Belldegrun, A.6
-
7
-
-
2142853538
-
Effect of papillary and chromophobe cell type on disease free survival after nephrectomy for renal cell carcinoma
-
Beck S, Patel M, Snyder M, Kattan M, Motzer R, Reuter V, Russo P (2003) Effect of papillary and chromophobe cell type on disease free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 11:71-77
-
(2003)
Ann Surg Oncol
, vol.11
, pp. 71-77
-
-
Beck, S.1
Patel, M.2
Snyder, M.3
Kattan, M.4
Motzer, R.5
Reuter, V.6
Russo, P.7
-
8
-
-
0023940009
-
Inflammatory bowel disease in a patient with nephropathic cystinosis
-
Treen W, Rusnack E, Ragsdale B, Seikaly M, DiPalma J (1988) Inflammatory bowel disease in a patient with nephropathic cystinosis. Pediatrics 81:584-587
-
(1988)
Pediatrics
, vol.81
, pp. 584-587
-
-
Treen, W.1
Rusnack, E.2
Ragsdale, B.3
Seikaly, M.4
DiPalma, J.5
-
9
-
-
0030051953
-
Ulcerative colitis complicated by renal cell carcinoma: A series of three patients
-
Satsangi J, Marshall J, Roskell D, Jewell D (1996) Ulcerative colitis complicated by renal cell carcinoma: A series of three patients. Gut 38:148-150
-
(1996)
Gut
, vol.38
, pp. 148-150
-
-
Satsangi, J.1
Marshall, J.2
Roskell, D.3
Jewell, D.4
-
10
-
-
0036024192
-
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
-
Fraser A, Orchard T, Robinson E, Jewell D (2002) Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 16:1225-1232
-
(2002)
Aliment Pharmacol Ther
, vol.16
, pp. 1225-1232
-
-
Fraser, A.1
Orchard, T.2
Robinson, E.3
Jewell, D.4
-
11
-
-
24644495220
-
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents
-
Kwon J, Farrell R (2005) The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol 56:169-178
-
(2005)
Crit Rev Oncol Hematol
, vol.56
, pp. 169-178
-
-
Kwon, J.1
Farrell, R.2
-
12
-
-
33846448180
-
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease
-
Masunaga Y, Ohno K, Ogawa R, Hashiguchi M, Echizen H, Ogata H (2007) Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother 41:21-28
-
(2007)
Ann Pharmacother
, vol.41
, pp. 21-28
-
-
Masunaga, Y.1
Ohno, K.2
Ogawa, R.3
Hashiguchi, M.4
Echizen, H.5
Ogata, H.6
-
13
-
-
0030007896
-
Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine
-
Jeitner TM, Renton FJ (1996) Inhibition of the proliferation of human neural neoplastic cell lines by cysteamine. Cancer Lett 103:85-90
-
(1996)
Cancer Lett
, vol.103
, pp. 85-90
-
-
Jeitner, T.M.1
Renton, F.J.2
-
14
-
-
0028082744
-
Rapid inactivation of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a potent mutagen in chlorinated drinking water, by sulfhydryl compounds
-
Watanabe M, Kobayashi H, Ohta T (1994) Rapid inactivation of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX), a potent mutagen in chlorinated drinking water, by sulfhydryl compounds. Mutat Res 312:131-138
-
(1994)
Mutat Res
, vol.312
, pp. 131-138
-
-
Watanabe, M.1
Kobayashi, H.2
Ohta, T.3
|